Xenon Pharmaceuticals Inc
NASDAQ:XENE
Income Statement
Earnings Waterfall
Xenon Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-214.1m
USD
|
Operating Income
|
-214.1m
USD
|
Other Expenses
|
31.7m
USD
|
Net Income
|
-182.4m
USD
|
Income Statement
Xenon Pharmaceuticals Inc
Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||
Revenue |
28
N/A
|
27
-3%
|
26
-5%
|
17
-34%
|
16
-10%
|
12
-22%
|
9
-30%
|
5
-45%
|
2
-61%
|
1
-32%
|
1
-32%
|
1
-18%
|
0
-54%
|
0
-3%
|
0
-7%
|
0
-93%
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
7
+95%
|
14
+104%
|
27
+96%
|
30
+11%
|
32
+6%
|
29
-8%
|
18
-38%
|
20
+9%
|
18
-7%
|
23
+24%
|
21
-7%
|
13
-38%
|
9
-28%
|
1
-93%
|
0
-81%
|
0
N/A
|
0
N/A
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(6)
N/A
|
(6)
0%
|
0
N/A
|
0
N/A
|
4
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(17)
|
(23)
|
(23)
|
(24)
|
(25)
|
(21)
|
(24)
|
(27)
|
(27)
|
(28)
|
(29)
|
(31)
|
(33)
|
(33)
|
(32)
|
(32)
|
(32)
|
(42)
|
(45)
|
(43)
|
(50)
|
(53)
|
(57)
|
(60)
|
(63)
|
(69)
|
(79)
|
(87)
|
(97)
|
(103)
|
(109)
|
(124)
|
(139)
|
(161)
|
(186)
|
(204)
|
(214)
|
|
Selling, General & Administrative |
(6)
|
(11)
|
(10)
|
(10)
|
(10)
|
(5)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(10)
|
(11)
|
(12)
|
(13)
|
(13)
|
(13)
|
(14)
|
(17)
|
(18)
|
(22)
|
(25)
|
(27)
|
(31)
|
(33)
|
(36)
|
(38)
|
(42)
|
(47)
|
|
Research & Development |
(12)
|
(13)
|
(14)
|
(14)
|
(15)
|
(16)
|
(18)
|
(20)
|
(20)
|
(21)
|
(22)
|
(24)
|
(26)
|
(25)
|
(25)
|
(24)
|
(24)
|
(27)
|
(30)
|
(34)
|
(39)
|
(42)
|
(44)
|
(47)
|
(51)
|
(55)
|
(63)
|
(69)
|
(75)
|
(79)
|
(82)
|
(93)
|
(106)
|
(126)
|
(148)
|
(161)
|
(168)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
11
N/A
|
4
-65%
|
3
-30%
|
(7)
N/A
|
(9)
-39%
|
(9)
+5%
|
(15)
-74%
|
(22)
-42%
|
(25)
-13%
|
(27)
-9%
|
(29)
-6%
|
(30)
-5%
|
(33)
-9%
|
(32)
+1%
|
(32)
+1%
|
(38)
-17%
|
(38)
-1%
|
(42)
-10%
|
(45)
-7%
|
(40)
+12%
|
(43)
-8%
|
(39)
+9%
|
(29)
+25%
|
(30)
-3%
|
(31)
-4%
|
(39)
-26%
|
(61)
-56%
|
(67)
-10%
|
(79)
-18%
|
(80)
-2%
|
(88)
-10%
|
(111)
-26%
|
(129)
-17%
|
(161)
-25%
|
(186)
-16%
|
(204)
-9%
|
(214)
-5%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
2
|
(1)
|
(0)
|
(4)
|
(6)
|
(1)
|
(2)
|
1
|
2
|
(0)
|
0
|
1
|
2
|
1
|
0
|
(1)
|
(1)
|
(0)
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
2
|
1
|
0
|
(3)
|
(4)
|
(3)
|
4
|
14
|
23
|
30
|
31
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
13
N/A
|
2
-81%
|
2
-2%
|
(11)
N/A
|
(16)
-49%
|
(10)
+37%
|
(17)
-73%
|
(21)
-23%
|
(23)
-10%
|
(27)
-18%
|
(29)
-5%
|
(29)
0%
|
(31)
-7%
|
(27)
+12%
|
(27)
-2%
|
(34)
-24%
|
(35)
-1%
|
(42)
-22%
|
(44)
-5%
|
(39)
+12%
|
(42)
-7%
|
(38)
+9%
|
(28)
+26%
|
(28)
-1%
|
(29)
-3%
|
(37)
-29%
|
(60)
-59%
|
(66)
-11%
|
(79)
-19%
|
(83)
-5%
|
(92)
-11%
|
(114)
-24%
|
(125)
-10%
|
(147)
-17%
|
(163)
-11%
|
(174)
-7%
|
(183)
-5%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
|
Income from Continuing Operations |
13
|
2
|
2
|
(11)
|
(16)
|
(10)
|
(17)
|
(21)
|
(23)
|
(27)
|
(29)
|
(29)
|
(31)
|
(27)
|
(27)
|
(34)
|
(35)
|
(42)
|
(44)
|
(39)
|
(42)
|
(38)
|
(28)
|
(28)
|
(29)
|
(37)
|
(59)
|
(66)
|
(79)
|
(83)
|
(92)
|
(114)
|
(125)
|
(147)
|
(164)
|
(175)
|
(182)
|
|
Net Income (Common) |
13
N/A
|
4
-70%
|
5
+30%
|
(2)
N/A
|
(16)
-556%
|
(10)
+37%
|
(17)
-73%
|
(21)
-23%
|
(23)
-10%
|
(27)
-18%
|
(29)
-5%
|
(29)
0%
|
(31)
-7%
|
(27)
+11%
|
(26)
+3%
|
(32)
-19%
|
(32)
0%
|
(38)
-22%
|
(41)
-8%
|
(37)
+10%
|
(40)
-7%
|
(36)
+9%
|
(27)
+26%
|
(27)
0%
|
(28)
-4%
|
(36)
-29%
|
(58)
-59%
|
(64)
-11%
|
(77)
-21%
|
(81)
-5%
|
(91)
-12%
|
(113)
-24%
|
(125)
-11%
|
(147)
-18%
|
(164)
-11%
|
(175)
-7%
|
(182)
-4%
|
|
EPS (Diluted) |
0.92
N/A
|
0.27
-71%
|
0.33
+22%
|
-0.16
N/A
|
-1.1
-588%
|
-0.69
+37%
|
-1.19
-72%
|
-1.37
-15%
|
-1.48
-8%
|
-1.51
-2%
|
-1.58
-5%
|
-1.6
-1%
|
-1.71
-7%
|
-1.79
-5%
|
-1.16
+35%
|
-1.55
-34%
|
-1.63
-5%
|
-1.49
+9%
|
-1.6
-7%
|
-1.44
+10%
|
-1.54
-7%
|
-1.09
+29%
|
-0.76
+30%
|
-0.77
-1%
|
-0.81
-5%
|
-0.86
-6%
|
-1.33
-55%
|
-1.55
-17%
|
-1.77
-14%
|
-1.45
+18%
|
-1.31
+10%
|
-1.72
-31%
|
-2.06
-20%
|
-2.24
-9%
|
-2.49
-11%
|
-2.65
-6%
|
-2.73
-3%
|